Practice
Featured experience
Chime $993.6 million IPO
The shares are listed on the Nasdaq Global Select Market
Cipher Mining 300 MW, $5.5 billion lease agreement with Amazon Web Services
We advised Cipher Mining on the transaction
Diameter Capital Partners $4.5 billion fundraise for its third dislocation fund
We advised Diameter on the transaction
Banco Santander $12.2 billion acquisition of Webster Bank
We are advising Banco Santander on the transaction
Davis Polk Advises Israel Chemicals Limited on Its $600 Million Senior Notes Offering and Concurrent Tender Offer
Davis Polk advised Israel Chemicals Limited in connection with its 144A/Regulation S notes offering of $600 million…
Davis Polk Advises Israel Chemicals Limited on Its $600 Million Senior Notes Offering and Concurrent Tender Offer
Davis Polk advised Israel Chemicals Limited in connection with its 144A/Regulation S notes offering of $600 million…
Davis Polk Advises Israel Chemicals Limited on Its $600 Million Senior Notes Offering and Concurrent Tender Offer
Davis Polk advised Israel Chemicals Limited in connection with its 144A/Regulation S notes offering of $600 million…
Iterum Therapeutics plc Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with Iterum Therapeutics plc’s initial…
Iterum Therapeutics plc Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with Iterum Therapeutics plc’s initial…
Davis Polk Advises GAIN Capital on the Sale of Its GTX ECN Business to Deutsche Börse Group’s FX unit, 360T
Davis Polk is advising GAIN Capital Holdings, Inc. on the $100 million sale of its GTX ECN business, an institutional…
Davis Polk Advises GAIN Capital on the Sale of Its GTX ECN Business to Deutsche Börse Group’s FX unit, 360T
Davis Polk is advising GAIN Capital Holdings, Inc. on the $100 million sale of its GTX ECN business, an institutional…
Davis Polk Advises GAIN Capital on the Sale of Its GTX ECN Business to Deutsche Börse Group’s FX unit, 360T
Davis Polk is advising GAIN Capital Holdings, Inc. on the $100 million sale of its GTX ECN business, an institutional…
Iterum Therapeutics plc Initial Public Offering
Davis Polk advised the representatives of the several underwriters in connection with Iterum Therapeutics plc’s initial…
Melinta Therapeutics, Inc. Common Stock Offering
Davis Polk advised the representatives of the underwriters in connection with the SEC-registered offering of 24,640,000…